Table 4 Univariate analysis and multivariate analysis of SNX10 and PTGDS expression among cervical cancer patients

Stage (I & II) vs Stage (III & IV)

2.338

1.364–4.004

0.002

3.078

1.329–7.129

0.009

Grade(G1 & G2) vs Grade(G3)

1.221

0.947–1.574

0.124

0.837

0.565–1.240

0.375

Age(≤50) vs Age(> 50)

1.263

0.755–2.112

0.373

1.197

0.711–2.011

0.498

SNX10 (high expression) vs SNX10 (low expression)

1.202

0.957–1.509

0.113

1.424

1.103–1.838

0.007

PTGDS (high expression) vs PTGDS (low expression)

0.838

0.729–0.962

0.012

0.802

0.693–0.928

0.003